Natural Health Trends (NHTC) Stock Forecast and Price Target (2026)

Last updated November 2026

Short answer

There is no meaningful price-target consensus for Natural Health Trends (NHTC): too few analysts publish a target on it for an average to mean anything. Thin coverage is normal for smaller and newer companies and says nothing about the business. No analyst publishes estimates on it either. What is left is the latest reported figures, the drivers and the risks below, which you assess yourself. Walnut is not an investment adviser.

Why NHTC has no consensus price target

Sell-side coverage follows trading volume and banking relationships, so smaller companies, recent listings, and names outside the major indices often carry little or none. NHTC is one of them. It says nothing about the quality of the business, but it does mean there is no informed average to anchor to, and that any single target you find elsewhere is one analyst's model.

By conventional measures NHTC looks extraordinarily cheap: the market cap is roughly 0.17x trailing revenue and about a third of the cash and marketable securities on the balance sheet, which implies a negative enterprise value of roughly ~$12M. That discount exists because the company is losing money, revenue is shrinking ~20% a year, and investors are uncertain how much of the cash will ever reach shareholders. The halved dividend, the July buyback resumption and the narrowing Q3 loss are the data points that could close the gap, but the stock fell further after the October 28 report. Continued burn and a sub-$1 listing problem could widen it.

NHTC: the latest reported figures

No analyst publishes estimates on NHTC, so these are the most recent figures we hold, as of November 2026. They describe where the company stands, not where it is going.

  • Revenue (TTM): ~$34M
  • Market cap: ~$5.8M (~$0.68 per share, Nov 20, 2026)
  • Cash and securities: ~$17.6M
  • Gross margin: ~75%
  • Operating loss (9M 2026): ~$1.4M
  • Shares outstanding: ~8.6M
  • Q3 2026 revenue: ~$7.6M, down ~20% year over year; net loss ~$232K

Is there a 2030 forecast for NHTC?

Not a published one. Analyst price targets run to about twelve months, occasionally two years, and the firms covering NHTC do not put out a 2030 number. Anything presenting one is extrapolating a growth rate of its own, and a figure produced that way tells you about the assumption chosen, not about the company.

What can be said over a long horizon is what the current price already assumes about the business, which is a question the filings answer and a forecast cannot.

For a ten-year question, that frame is more useful. A share price is the market’s estimate of future cash flows discounted to today, so the multiple is already a statement about growth. The long-horizon question is whether Natural Health Trends can deliver what is priced in, and what would have to change for that to break. Both are answerable from the drivers and risks below. A number for 2030 is not.

What could move NHTC from here

In short: the drivers cited most often are Stabilizing the Hong Kong and China business, Restructuring and cost discipline, Capital returns and the cash cushion. The risk cited most often against it is the most immediate risk is the listing.

Both sides are worked through properly, with the high and low targets used as the bull and bear anchors, on the NHTC is it a buy page.

Your questions about Natural Health Trends

Ask Walnut's AI anything about NHTC and see how it fits what you own.

FAQ

Why does NHTC have no analyst forecast?

+

Sell-side coverage follows trading volume and banking relationships, so small caps, recent listings, and companies outside the major indices often carry little or none. A lack of coverage says nothing about the business itself. It does mean the analysis starts with you, because there is no published model to build on.

What could move NHTC?

+

The drivers and the risks are laid out on this page and in more depth on the NHTC "is it a buy" page. Without analyst estimates to anchor to, the useful framing is a set of scenarios.

Walnut is informational, not investment advice, and does not publish price targets of its own. The analyst figures on this page come from a November 2026 data pull of published third-party research, are approximate, and change constantly. The share price is the last one Yahoo Finance reported on November 20, 2026, and every percentage against it on this page is measured from that price. Verify current figures with your broker before acting on them.

Forecasts for similar stocks